HomeRMTI • NASDAQ
Follow
Rockwell Medical Inc
Previous close
$1.64
Day range
$1.60 - $1.70
Year range
$1.16 - $6.24
Market cap
48.70M USD
Avg Volume
272.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 23.77M | 27.18% |
Operating expense | 3.94M | -12.17% |
Net income | -1.87M | 55.32% |
Net profit margin | -7.88 | 64.85% |
Earnings per share | -0.09 | 78.25% |
EBITDA | -1.17M | 67.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.73M | -57.44% |
Total assets | 52.61M | -2.92% |
Total liabilities | 31.09M | -18.30% |
Total equity | 21.52M | — |
Shares outstanding | 28.49M | — |
Price to book | 2.16 | — |
Return on assets | -9.58% | — |
Return on capital | -14.02% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -1.87M | 55.32% |
Cash from operations | -3.75M | -240.56% |
Cash from investing | -10.29M | 29.97% |
Cash from financing | 12.84M | 741.61% |
Net change in cash | -1.20M | 93.26% |
Free cash flow | -1.01M | -98.92% |
About
Rockwell Medical Inc. is a company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease.
The company's primary customers are dialysis providers. Wikipedia
Founded
1996
Headquarters
Website
Employees
253